Texas Oncology Foundation Inc (EIN 752705785) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1997

Legal Domicile

Principal Officer

J ERNEST SIMS

Phone

9724902930

Tax Period

2024-01-01 to 2024-12-31

Texas Oncology Foundation Inc, founded in 1997, is a community nonprofit in the Medical Research sector that reported $2.1M in total revenue in fiscal year 2024. Revenue surged 68% from the prior year, signaling strong growth momentum. The organization ran a surplus of $867K, a strong 41% operating margin.

Mission

THE ORGANIZATION INTENDS TO OPERATE FOR THE PURPOSE OF PATIENT AND COMMUNITY EDUCATION AND SUPPORT, AND FINANCIAL ASSISTANCE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,261,208

Program Service Revenue $0

Investment Income $57,041

Other Revenue $-205,353

TOTAL REVENUE $2,112,896

Expense Breakdown

Grants Paid $536,045

Salaries & Benefits $367,008

Fundraising Expenses $137,211

Program Expenses $905,347

Other Expenses $343,122

TOTAL EXPENSES $1,246,175

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,112,896	$1,254,018	+0.7%
Expenses	$1,246,175	$1,032,126	+0.2%
Net Income	$866,721	$221,892	+2.9%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

160

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$199,423

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Natalie Q O'Roark	Executive Director	40.0	Officer	$157,473	$41,950	$199,423
Kathryn Hudson MD	Chairman	1.0	Officer Director	$0	$0	$0
J Ernest Sims	PRESIDENT	3.0	Officer Director	$0	$0	$0
R Steven Paulson MD	TREASURER	1.0	Officer Director	$0	$0	$0
LAWRENCE FRASE MD	SECRETARY	1.0	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,112,896	$1,246,175	$3,549,379	$866,721
2023	$1,254,018	$1,032,126	$2,711,305	$221,892
2022	$1,038,531	$711,928	$2,414,036	$326,603
2021	$1,014,114	$593,728	$2,137,196	$420,386
2020	$527,029	$563,215	$1,696,172	$-36,186
2019	$736,946	$722,610	$1,726,020	$14,336
2018	$572,783	$634,308	$1,701,593	$-61,525

Texas Oncology Foundation Inc